Filing Details

Accession Number:
0001225208-16-040863
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-31 16:34:28
Reporting Period:
2016-10-28
Filing Date:
2016-10-31
Accepted Time:
2016-10-31 16:34:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1271440 S Christopher Holland C/O C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974
Senior Vice President And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-10-28 3,971 $95.99 29,689 No 4 M Direct
Common Stock Disposition 2016-10-28 1,396 $212.78 28,293 No 4 S Direct
Common Stock Disposition 2016-10-28 1,503 $211.34 26,790 No 4 S Direct
Common Stock Disposition 2016-10-28 2,825 $210.18 23,965 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2016-10-28 3,971 $0.00 3,971 $95.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-06-01 No 4 M Direct
Footnotes
  1. Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
  2. Includes 80.455 shares acquired under the Company's Employee Stock Purchase Plan from May 17, 2016 to August 1, 2016.
  3. Represents the weighted average sales price for price increments ranging from $212.39 to $213.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  4. Represents the weighted average sales price for price increments ranging from $211.08 to $211.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  5. Represents the weighted average sales price for price increments ranging from $210.00 to $210.41. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  6. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  7. Options fully vested and are currently exercisable.